P3 Health Partners (PIIIW) Competitors $0.01 0.00 (-11.02%) As of 05/1/2025 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PIIIW vs. ACONW, AONC, DHACW, LFMDP, OTRKP, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings, profitability and community ranking. Which has higher valuation & earnings, ACONW or PIIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$45.72KN/AN/AN/AN/AP3 Health Partners$1.50BN/AN/AN/AN/A Does the MarketBeat Community prefer ACONW or PIIIW? Aclarion and P3 Health Partners both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AP3 Health PartnersN/AN/A Does the media refer more to ACONW or PIIIW? In the previous week, Aclarion and Aclarion both had 1 articles in the media. P3 Health Partners' average media sentiment score of 1.89 beat Aclarion's score of 1.87 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Very Positive P3 Health Partners Very Positive Is ACONW or PIIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A P3 Health Partners N/A N/A N/A SummaryP3 Health Partners beats Aclarion on 2 of the 2 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIIIW vs. The Competition Export to ExcelMetricP3 Health PartnersMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.49B$5.54B$7.93BDividend YieldN/A3.83%5.09%4.23%P/E RatioN/A7.0022.6018.55Price / SalesN/A11.89400.01103.29Price / CashN/A12.5138.1834.62Price / BookN/A1.896.774.25Net IncomeN/A$58.65M$3.22B$248.18M7 Day PerformanceN/A-1.51%1.10%0.91%1 Month PerformanceN/A0.02%2.48%2.58%1 Year PerformanceN/A9.83%15.71%4.02% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIWP3 Health PartnersN/A$0.01-11.0%N/A-83.8%$0.00$1.50B0.00500Positive NewsGap DownHigh Trading VolumeACONWAclarionN/A$0.04-11.1%N/A-34.7%$0.00$45,724.000.007Positive NewsAONCAmerican Oncology NetworkN/A$5.60+9.6%N/A+56.1%$0.00$1.34B0.001,520News CoverageGap DownDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$24.53+3.0%N/A+6.1%$0.00$212.45M0.00230Upcoming EarningsGap UpOTRKPOntrakN/A$0.23-2.6%N/A-51.8%$0.00$10.84M0.00250TALKWTalkspaceN/A$0.10+2.1%N/A-44.8%$0.00$187.59M0.00500Positive NewsTOIIWOncology InstituteN/A$0.07+61.0%N/A-65.8%$0.00$393.41M0.00660Short Interest ↓NTRANatera2.8707 of 5 stars$148.56+2.7%$175.76+18.3%+60.8%$20.08B$1.70B-84.413,020Upcoming EarningsInsider TradePositive NewsFMSFresenius Medical Care3.8416 of 5 stars$23.64-1.5%$25.30+7.0%+18.0%$13.87B$19.34B19.54123,200Upcoming EarningsPositive NewsHIMSHims & Hers Health2.3704 of 5 stars$26.75+5.5%$38.25+43.0%+191.3%$5.94B$1.48B60.80650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews Coverage Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors LifeMD Competitors Ontrak Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Fresenius Medical Care Competitors Hims & Hers Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIIIW) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PIIIW Stock Free PIIIW Stock Alerts